* Nivolumab Erfahrungsberichte (updated 2024-10-29) ~ youtor.org

Nivolumab Erfahrungsberichte (updated 2024-10-29)

Informationen zu Nivolumab Opdivo [upl. by Yneffit]

Informationen zu Nivolumab Opdivo

Duration: 10:03
4,6K weergaven | 26 apr. 2016

Nivolumab A New StandardofCare [upl. by Awhsoj885]

Nivolumab A New StandardofCare

Duration: 6:10
6,2K weergaven | 20 feb. 2017

Opdivo nivolumab the Immunotherapy Cancer Treatment [upl. by Jamieson]

Opdivo nivolumab the Immunotherapy Cancer Treatment

Duration: 3:12
71,5K weergaven | 3 jun. 2016

Nivolumab Plus Ipilimumab in Advanced Melanoma [upl. by Zetrac]

Nivolumab Plus Ipilimumab in Advanced Melanoma

Duration: 5:39
7,8K weergaven | 15 okt. 2014

Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers [upl. by Marlie]

Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers

Duration: 2:00
1,2K weergaven | 2 maanden geleden

Audio Described Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers [upl. by Tani]

Audio Described Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers

Duration: 2:55
1,3K weergaven | 2 maanden geleden

1 Eerste infuus Immuuntherapie Nivolumab [upl. by Euqinobe826]

1 Eerste infuus Immuuntherapie Nivolumab

Duration: 3:09
1,4K weergaven | 17 jan. 2019

Nivolumab improves overall survival for advanced kidney cancer [upl. by Emsoc385]

Nivolumab improves overall survival for advanced kidney cancer

Duration: 3:23
1,1K weergaven | 20 nov. 2015

Nivolumab plus lowdose ipilimumab promising for treatmentnaïve MSIhigh mCRC HeinzJosef Lenz [upl. by Ikcaj]

Nivolumab plus lowdose ipilimumab promising for treatmentnaïve MSIhigh mCRC HeinzJosef Lenz

Duration: 5:59
97 weergaven | 25 mrt. 2019

Dr Andre on the Efficacy of NivolumabIpilimumab in MSIHdMMR mCRC Subgroups [upl. by Lyram941]

Dr Andre on the Efficacy of NivolumabIpilimumab in MSIHdMMR mCRC Subgroups

Duration: 2:30
95 weergaven | 1 maand geleden

Phase II trial of nivolumab plus ipilimumab in advanced bladder cancer of variant histologies [upl. by Naffets]

Phase II trial of nivolumab plus ipilimumab in advanced bladder cancer of variant histologies

Duration: 1:58
137 weergaven | 27 okt. 2023

FirstLine NivolumabIpilimumab Improves Survival in Unresectable Hepatocellular Carcinoma [upl. by Salokin660]

FirstLine NivolumabIpilimumab Improves Survival in Unresectable Hepatocellular Carcinoma

Duration: 4:46
1 weergaven | 4 maanden geleden

Adding nivolumab to neoadjuvant chemo improves response rate for high risk ER HER2− breast cancer [upl. by Airemahs]

Adding nivolumab to neoadjuvant chemo improves response rate for high risk ER HER2− breast cancer

Duration: 2:05
814 weergaven | 8 nov. 2017

Dr Weber on the Toxicity Profile of Nivolumab Versus Ipilimumab for Melanoma

Duration: 2:10
131 weergaven | 3 maanden geleden

Safety and efficacy of RP2 alone or with nivolumab for uveal melanoma [upl. by Warenne726]

Safety and efficacy of RP2 alone or with nivolumab for uveal melanoma

Duration: 1:40
37 weergaven | 4 maanden geleden

Nivolumab plus ipilimumab shows clinical benefit as firstline treatment for centrally confirmed [upl. by Marysa]

Nivolumab plus ipilimumab shows clinical benefit as firstline treatment for centrally confirmed

Duration: 3:48
1,3K weergaven | 5 maanden geleden

Nivolumab plus gemcitabinecisplatin shows benefit for locally advanced mUC [upl. by Herzberg1]

Nivolumab plus gemcitabinecisplatin shows benefit for locally advanced mUC

Duration: 2:07
63 weergaven | 6 maanden geleden

Perioperative Nivolumab in Resectable NSCLC NEJM [upl. by Eirrok]

Perioperative Nivolumab in Resectable NSCLC NEJM

Duration: 2:24
258 weergaven | 11 maanden geleden

Nivolumab Combo Phase 3 TiNivo 2 Results Tivozanib in RCC Presented at ESMO 2024 AVEO [upl. by Einavoj]

Nivolumab Combo Phase 3 TiNivo 2 Results Tivozanib in RCC Presented at ESMO 2024 AVEO

Duration: 2:54
224 weergaven | 17 jun. 2016

Checkmate 77T Perioperative Nivolumab in NSCLC OncTalk Lung 2023 [upl. by Stearn]

Checkmate 77T Perioperative Nivolumab in NSCLC OncTalk Lung 2023

Duration: 1:24
691 weergaven | 1 week geleden

2yr RELATIVITY047 nivolumab relatlimab in previously untreated metastaticunresectable melanoma [upl. by Edla467]

2yr RELATIVITY047 nivolumab relatlimab in previously untreated metastaticunresectable melanoma

Duration: 1:56
427 weergaven | 28 sep. 2018

Nivolumab and pembrolizumab and the current treatment landscape for Hodgkin lymphoma [upl. by Sadella]

Nivolumab and pembrolizumab and the current treatment landscape for Hodgkin lymphoma

Duration: 0:35
87 weergaven | 3 weken geleden

Nivolumab in Advanced Hodgkin’s Lymphoma NEJM [upl. by Ecyla]

Nivolumab in Advanced Hodgkin’s Lymphoma NEJM

Duration: 2:28
502 weergaven | 22 jun. 2017

Nivolumab and Checkpoint Inhibitors in HCC [upl. by Dane]

Nivolumab and Checkpoint Inhibitors in HCC

Duration: 5:20
156 weergaven | 1 maand geleden

Dr Awad on the FDA Approval of Perioperative Nivolumab for Resectable NSCLC [upl. by Yeruoc]

Dr Awad on the FDA Approval of Perioperative Nivolumab for Resectable NSCLC

Duration: 4:22
12 weergaven | 1 maand geleden

Nivolumab With or Without Ipilimumab in Gastroesophageal Junction Cancer [upl. by Goody871]

Nivolumab With or Without Ipilimumab in Gastroesophageal Junction Cancer

Duration: 3:47
504 weergaven | 3 weken geleden

NADINA trial neoadjuvant ipilimumab nivolumab shows superior EFS in resectable stage III melanoma [upl. by Naillik]

NADINA trial neoadjuvant ipilimumab nivolumab shows superior EFS in resectable stage III melanoma

Duration: 2:48
136 weergaven | 6 maanden geleden

Addition of relatlimab to nivolumab plus platinumdoublet chemotherapy demonstrates improved cli [upl. by Akirahs]

Addition of relatlimab to nivolumab plus platinumdoublet chemotherapy demonstrates improved cli

Duration: 4:21
|

Dr Awad on the FDA Approval of Perioperative Nivolumab for Resectable NSCLC lungcancer fda [upl. by Hildagarde]

Dr Awad on the FDA Approval of Perioperative Nivolumab for Resectable NSCLC lungcancer fda

Duration: 0:58
|

Checkmate 816 Neoadjuvant Nivolumab Chemotherapy for NSCLC OncTalk Lung 2023 [upl. by Lounge540]

Checkmate 816 Neoadjuvant Nivolumab Chemotherapy for NSCLC OncTalk Lung 2023

Duration: 3:25
|

YTube is the largest video sharing platform on the Internet. Millions of new videos appear on it every day. You can find a wide variety of videos, but YTube does not offer a FREE download service Our site allows you to download your favorite YTube videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024